Wolverine Trading, LLC Theravance Biopharma, Inc. Call Options Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$8.41 - $10.34 $86,623 - $106,502	-10,300 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.33 - $12.96 $85,799 - $133,488	10,300 New	10,300 $98,000
Q4 2021 Feb 14, 2022	SELL	$7.42 - $11.05 $294,574 - $438,685	-39,700 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.77 - $14.41 $268,769 - $572,077	39,700 New	39,700 $295,000
Q2 2021 Aug 06, 2021	SELL	$14.52 - $22.46 $142,296 - $220,108	-9,800 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$16.57 - $21.08 $162,386 - $206,583	9,800 New	9,800 $202,000
Q1 2020 May 11, 2020	SELL	$17.84 - $31.21 $233,704 - $408,851	-13,100 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$16.12 - $25.89 $116,064 - $186,408	7,200 Added 122.03%	13,100 $338,000
Q3 2017 Nov 15, 2017	BUY	$23.88 - $34.96 $140,892 - $206,264	5,900	5,900 $202,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $658M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.